SEC Form 3 · accession 0001209191-15-066582
Axovant Sciences Ltd. · AXON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Adasczik
Officer — Principal Accounting Officer
Period of report
Aug 12, 2015
Accepted (ET)
Aug 18, 2015 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001636050
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit List - Exhibit 24 -Power of Attorney